CG Oncology’s late-stage bladder cancer treatment notched a complete response in roughly three-quarters of treated patients, fueling optimism that the company’s Wall Street success story is no fluke.

In a move that will be seized on as a sign that the IPO window is reopening in 2023, CG Oncology has not only become the first biotech to go public this year but overshot its own estimates. The ...

When bladder cancer does not respond to the current standard of care therapy, the next treatment option is surgery to completely remove the bladder. CG Oncology aims to give patients another choice.

The Carlyle Group Inc. (NASDAQ:CG) is among the 12 Best Very Cheap Stocks to Buy in 2026. On March 2, Barclays lowered the ...

Communications firm CG Life rolled out a brand refresh Wednesday morning to highlight its commitment to science. The Shaped by Science rebrand seeks to underscore the inspiration behind the agency’s ...

View Carlyle Group Inc CG stock quote prices, financial information, real-time forecasts, and company news from CNN.

CHICAGO & SAN DIEGO--(BUSINESS WIRE)--CG Life, an integrated digital marketing and communications agency specializing in life science and healthcare, today announced David Ormesher as chief executive ...

CG Life has found what it is looking for in Toolhouse, inking a deal to buy the digital agency for the tools to chisel out the next chapter in its story. Seattle-based Toolhouse, which set up shop in ...